{"disease":{"id":"raynaud-phenomenon","name":"raynaud phenomenon"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02202291","title":"Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon","phase":"NA","overall_status":"COMPLETED","enrollment_count":258,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04040322","title":"Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":198,"lead_sponsor_name":"Civi Biopharma, Inc.","has_results":true},{"nct_id":"NCT03094910","title":"Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon","phase":"NA","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Herlev Hospital","has_results":false},{"nct_id":"NCT03984422","title":"Application for Monitoring and Evaluation of Raynaud's Phenomenon","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT06291142","title":"Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot","phase":"","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"University of Manchester","has_results":false},{"nct_id":"NCT04644523","title":"Dermoscopy in Primary Raynaud's Phenomenon","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03717961","title":"Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03699436","title":"Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Universidad de Granada","has_results":false},{"nct_id":"NCT04015193","title":"Follow-up of SPTS in Patients With Raynaud's Phenomenon","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT03867097","title":"Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Civi Biopharma, Inc.","has_results":true},{"nct_id":"NCT03749577","title":"Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT03211325","title":"Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT03129178","title":"Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon","phase":"NA","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"University of Portsmouth","has_results":true},{"nct_id":"NCT03815162","title":"Cocoa Flavanol Supplementation in Raynaud's Phenomenon","phase":"NA","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT04854850","title":"Apollo Device for Fatigue in Systemic Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Robyn T. Domsic, MD, MPH","has_results":true},{"nct_id":"NCT04388176","title":"Cold Challenge With C21 in RP","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Vicore Pharma AB","has_results":true},{"nct_id":"NCT04915950","title":"A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03869008","title":"Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"University of Toledo Health Science Campus","has_results":true},{"nct_id":"NCT03972566","title":"Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon","phase":"","overall_status":"UNKNOWN","enrollment_count":5,"lead_sponsor_name":"RoseLab Skin Optics Laboratory","has_results":false},{"nct_id":"NCT03639766","title":"The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"University of Central Florida","has_results":true}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}